Navigation Links
Global Next Generation Sequencing (NGS) Market Report 2013-2017
Date:12/12/2013

DUBLIN, Dec. 12, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/554xlp/next_generation) has announced the addition of the "Global Next Generation Sequencing (NGS) Market Report 2013-2017" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769 

The NGS platforms market was dominated by Illumina in 2012, which accounted for the largest market share of 56%. Other companies with commercial platforms include Life Technologies (U.S.), 454 Roche (U.S.), and Pacific Biosciences (U.S.). The recently introduced Bench-top and NGS platforms will drive the market. Based on steps in the NGS workflow, the overall NGS market has three major segments, namely, pre-sequencing, NGS platforms and services, and NGS data analysis, storage and management.

The raw sequencing data generated by today's sequencers does not reflect on any meaningful information in itself. Also, open source tools for analyzing NGS data require adequate bioinformatics training. These factors open up huge opportunities for commercial NGS bioinformatics software, workbenches, and services, whose market is currently fragmented and has a relatively smaller size. Whole genome sequencing, targeted re-sequencing, de novo sequencing, RNA-Seq, ChIP-Seq and methyl-Seq are the major applications that use NGS data analysis tools and services. Key players like CLC bio (Denmark), Biomatters (New Zealand), Partek (U.S.), Genomatix (Germany), Knome (U.S.), and DNASTAR (U.S.) dominate this market space.

Key Topics Covered:

1 Introduction
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology

2 Executive Summary

3 Market Overview
3.1 Introduction
3.2 Evolution
3.3 Market Segmentation
3.4 Market Dynamics
3.5 Porter's Five Forces Analysis
3.6 Value Chain
3.7 Technological Development Road-Map
3.8 Technological Trends
3.9 End-User Analysis
3.10 Market Share Analysis

4 Global Ngs Market, By Steps In Workflow
4.1 Introduction
4.2 Pre-Sequencing Products & Services Market
4.3 Sequencing Platforms Market
4.4 Sequencing Services Market
4.5 NGS Data Analysis, Storage And Management (Bioinformatics) Market

5 NGS Technology Market
5.1 Introduction
5.2 Sequencing By Synthesis (SBS)
5.3 ION Semiconductor Sequencing
5.4 Sequencing By Ligation (SBL)
5.5 Pyrosequencing
5.6 Single-Molecule Real-Time Sequencing (SMRT)

6 Global NGS Application Market
6.1 Introduction
6.2 Diagnostics
6.3 Drug Discovery
6.4 Biomarker Discovery
6.5 Personalized Medicine
6.6 Agriculture & Animal Research
6.7 Other Applications

7 Geographic Analysis

8 Competitive Landscape
8.1 Introduction
8.2 Mergers & Acquisitions
8.3 Agreements, Partnerships, Collaborations & Joint Ventures
8.4 New Product Launch
8.5 Expansion

9 Company Profiles

Companies Mentioned:

  • Agilent Technologies, Inc
  • BGI (Beijing Genomics Institute)
  • Biomatters, Ltd
  • CLC Bio
  • Dnastar, Inc
  • EMC Corporation
  • GATC biotech AG
  • Genomatix Software GMBH
  • Illumina, Inc
  • Knome, Inc
  • Life Sciences Corporation (A Roche Company)
  • Life Technologies Corporation
  • Macrogen, Inc
  • Ocimum Biosolutions, Ltd
  • Oxford Nanorpore Technologies, Ltd
  • Pacific Biosciences
  • Partek Incorporated
  • Perkinelmer, Inc
  • Qiagen NV
  • Strand Life Sciences Pvt Ltd

For more information visit http://www.researchandmarkets.com/research/554xlp/next_generation

Media Contact:

Laura Wood , +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Biomarker Market for Diagnostic Applications is Expected to Reach $30.6 Billion Globally by 2020 - Allied Market Research
2. Global Geosynthetics Market 2012-2016
3. ITRA Global’s Detroit Affiliate Awarded Contract to Manage Real Estate for Michigan’s Western and Southeastern Regions
4. Increasing Focus on Customization of Healthcare Drives the Market for Personalized Medicine, According to a Soon to be Released Report by Global Industry Analysts, Inc.
5. Growing Interest in Regenerative Medicine to Drive the Mesenchymal Stem Cells Market, According to a Soon to Be Released Report by Global Industry Analysts, Inc.
6. Global And China PAR Industry 2013 Market Research Report
7. Agricultural Biotechnology: Transgenic Seeds/Crops and Biopesticides - Global Strategic Business Report - 2012-2018
8. Robust Demand for Skincare Cosmeceuticals Drives the Global Cosmetic Chemicals Market, According to New Report by Global Industry Analysts, Inc.
9. RSNA Partners with TEMIS to Deliver Smarter Content to its Global Community of Radiologists
10. Myriant Selected as a 2013 Red Herring Top 100 Global Company
11. Global Carbonates Report in Detail Analysis 2013: Worldwide Industry Share, Investment Trends, Growth, Size, Strategy and Forecast Research Report 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... , ... Having proven that its Disruptor™ technology is more ... Green Cell Technologies® (GCT®), has turned its attention to the lucrative fruit ... methods, ushering in a new era of modern, cost effective and more natural ...
(Date:8/22/2017)... ... 22, 2017 , ... Cutting Edge Spine , a ... spinal implant technologies, announced today the appointment of Luke Maher as Director U.S. ... experience to directing Cutting Edge Spine’s national sales force, including 12+ years at ...
(Date:8/21/2017)... Kamuela/Waimea (PRWEB) , ... August 21, 2017 , ... ... based on the Big Island of Hawaii, is pleased to announce the first ... Trudeau, R(S) of MacArthur Sotheby’s International Realty is working together with listing agent ...
(Date:8/21/2017)... , ... August 21, 2017 , ... ... two speakers for this two-part educational webinar, in which attendees will learn about ... associated protein factor composition. Along with an overview of the development and validation ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... 30, 2017 Trends, opportunities and forecast in ... by technology (fingerprint, AFIS, iris recognition, facial recognition, hand ... by end use industry (government and law enforcement, commercial ... banking, and others), and by region ( North ... Asia Pacific , and the Rest of ...
(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
Breaking Biology News(10 mins):